We are monitoring the impact of COVID-19 on MEA Companion Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 593
Share on
Share on

Middle East & Africa Companion Diagnostics Market Research Report – Segmented By Indication, By Technology & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 593
Pages: 145

MEA Companion Diagnostics Market Size (2021 to 2026)

As per our report, the size of the Companion Diagnostics Market in the Middle East & Africa was worth USD 0.13 billion in 2021 and is estimated to be growing at a CAGR of 21.11% to reach USD 0.35 billion by 2026.

Companion diagnostic has the potential to modify the drug development process, and the commercialization of the drug diagnoses will make drugs with better therapeutic efficiency in a faster and cost-effective way. In addition, companion diagnostics has been highly advantageous for identifying patients with precise biomarkers with predictive responses.

Innovative technologies such as next-generation sequencing (NGS), growing acceptance of companion diagnostic kits/tests by the pharmaceutical industry, and boost from controlling bodies are anticipated to enhance the market. NGS-based companion diagnostics is one of the significant factors that are expected to drive the companion diagnostics market in the Middle East and African region due to its ability to identify multiple genes at a single time.

Regulatory uncertainty and cost allied with developing drugs are expected to hamper the growth of the MEA companion diagnostics market during the forecast period.

This research report on the Middle East and Africa Companion Diagnostics Market has been segmented and sub-segmented into the following categories:

By Indications:

  • Oncology
    • Colorectal Cancer
    • Lung Cancer
    • Breast Cancer
    • Gastric Cancer
    • Melanoma
  • Inflammation and Autoimmune Diseases
  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Virology Diseases

By Technology:

  • Immunohistochemistry
  • Molecular Diagnostics
    • In-Situ Hybridization
    • Real-Time PCR
    • Gene Sequencing

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Regionally, the African companion diagnostics market is expected to grow at the highest CAGR in this region during the forecast period. On the other hand, the Middle East companion diagnostics market is estimated to have a sluggish growth rate during the forecast period. This region's growth is attributed to factors such as the growing need for improved personalized patient treatment, which has contributed to healthcare providers. Also, growing support from government reimbursement policies for bringing out better treatment in ordinary people accelerates the companion diagnostics market growth over the analysis period.

The South African market is expected to grow at a notable rate during the forecast period. The growth of Africa has contributed towards the companion diagnostics market due to factors such as increasing acceptance for diagnostics tests/kits by the pharmaceutical industry, reimbursement policies made by the government are likely to anticipate the market of this region. However, the cost related to this diagnostics market is so expensive, and the lack of lab technicians and lack of infrastructure in the diagnostics centers may hinder the companion diagnostics market growth over the forecast period.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the MEA Companion Diagnostics Market profiled in this report are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc., Biogenex Laboratories Inc., Ventana Medical Systems Inc., and Thermo Fisher Scientific Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Companion Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  2. Middle East & Africa Companion Diagnostics Market By Indication, From 2021 to 2026 (USD Billion)
  3. Middle East & Africa Oncology Market By Region, From 2021 to 2026 (USD Billion)
  4. Middle East & Africa Inflammation and Autoimmune Diseases Market By Region, From 2021 to 2026 (USD Billion)
  5. Middle East & Africa Cardiovascular Diseases Market By Region, From 2021 to 2026 (USD Billion)
  6. Middle East & Africa Central Nervous System Disorders Market By Region, From 2021 to 2026 (USD Billion)
  7. Middle East & Africa Virology Diseases Market By Region, From 2021 to 2026 (USD Billion)
  8. Middle East & Africa Companion Diagnostics Market By Technology, From 2021 to 2026 (USD Billion)
  9. Middle East & Africa Immuno Histochemistry Market By Region, From 2021 to 2026 (USD Billion)
  10. Middle East & Africa Molecular Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  11. Middle East & Africa Oncology Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  12. Middle East & Africa Colorectal Cancer Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  13. Middle East & Africa Breast Cancer Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  14. Middle East & Africa Lung Cancer Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  15. Middle East & Africa Gastric Cancer Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  16. Middle East & Africa Melanoma Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  17. Middle East & Africa Molecular Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  18. Middle East & Africa In-Situ Hybridization Market By Region, From 2021 to 2026 (USD Billion)
  19. Middle East & Africa Real Time PCR Market By Region, From 2021 to 2026 (USD Billion)
  20. Middle East & Africa Gene Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  21. Middle East Companion Diagnostics Market By Indication, From 2021 to 2026 (USD Billion)
  22. Middle East Companion Diagnostics Market By Technology, From 2021 to 2026 (USD Billion)
  23. Middle East Oncology Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  24. Middle East Molecular Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  25. Africa Companion Diagnostics Market By Indication, From 2021 to 2026 (USD Billion)
  26. Africa Companion Diagnostics Market By Technology, From 2021 to 2026 (USD Billion)
  27. Africa Oncology Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  28. Africa Molecular Diagnostics Market By Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample